Bandwidth, C3.ai, Domo, Five9, and Health Catalyst Shares Are Soaring, What You Need To KnowA number of stocks jumped in the afternoon session after positive news on corporate earnings, easing political and trade tensions, and optimism about future interest rate cuts all converged to lift investor sentiment.
Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
3 Cash-Burning Stocks We’re Skeptical OfRapid spending isn’t always a sign of progress.
Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.
1 Oversold Stock Set for a Comeback and 2 We IgnoreRock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Upland Software, Health Catalyst, SoundHound AI, BILL, and DigitalOcean Stocks Trade Down, What You Need To KnowA number of stocks fell in the afternoon session after President Trump threatened to increase import taxes on Chinese goods, reigniting trade war fears.
Health Catalyst, Upstart, ON24, Semrush, and Flywire Shares Plummet, What You Need To KnowA number of stocks fell in the afternoon session after markets pulled back as a report raised concerns about artificial intelligence demand and profitability.
3 Volatile Stocks with Open QuestionsMarket swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
Health Catalyst, Twilio, Palantir Technologies, Zscaler, and Appian Shares Skyrocket, What You Need To KnowA number of stocks jumped in the afternoon session after investors scooped up equities, shaking off the initial concerns inferred from the Fed's dot plot, with tech stocks leading the charge.
3 Value Stocks with Open QuestionsThe low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
3 Unprofitable Stocks with Open QuestionsRunning at a loss can be a red flag.
Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Okta, Asana, PagerDuty, Appian, and Health Catalyst Shares Plummet, What You Need To KnowA number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
Winners And Losers Of Q2: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics StocksWrapping up Q2 earnings, we look at the numbers and key takeaways for the data analytics stocks, including Amplitude (
NASDAQ:AMPL) and its peers.
3 Small-Cap Stocks We’re Skeptical OfInvestors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Health Catalyst (HCAT) Stock Trades Down, Here Is WhyShares of healthcare data analytics company Health Catalyst (
NASDAQ:HCAT) fell 4.1% in the morning session after Piper Sandler downgraded the stock's rating to Neutral from Overweight and slashed its price target in half.
Health Catalyst to Participate in Upcoming Investor ConferencesSALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
3 Volatile Stocks We Keep Off Our RadarVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
C3.ai, Health Catalyst, Upstart, Semrush, and Flywire Shares Are Falling, What You Need To KnowA number of stocks fell in the afternoon session after markets pulled back as a hotter-than-expected wholesale inflation report for July dampened hopes for a Federal Reserve interest rate cut. The U.S. Producer Price Index (PPI), a key measure of wholesale inflation, rose 0.9% month-over-month in July, far exceeding the 0.2% increase that economists had predicted. Annually, prices at the wholesale level jumped 3.3%, also surpassing the 2.5% forecast. This hotter-than-expected data has poured cold water on widespread expectations for an interest rate cut from the Federal Reserve next month. Persistent inflation makes it less likely for the central bank to ease monetary policy. Sectors with high-growth stocks, such as SaaS, are particularly sensitive to interest rate changes, as the prospect of higher rates for longer can diminish the present value of their future earnings, leading to a decline in stock prices.
nCino, C3.ai, Five9, Health Catalyst, and RingCentral Shares Are Soaring, What You Need To KnowA number of stocks jumped in the afternoon session after the SaaS sector continued to rally as favorable inflation data bolstered hopes for a Federal Reserve interest rate cut. This optimism was largely driven by a benign July Consumer Price Index (CPI) report, which solidified investor expectations for a Federal Reserve interest rate cut. Following the release of the inflation data, which showed a year-over-year increase of 2.7%, the probability of a rate cut in September surged to over 96%. Lower interest rates are typically beneficial for growth-oriented technology stocks, as they can reduce borrowing costs and increase the present value of future earnings. Adding to the positive sentiment was a 90-day delay in the imposition of higher tariffs on Chinese goods, which reduced trade-related uncertainty for the technology sector.
C3.ai, Health Catalyst, Wix, Jamf, and ON24 Shares Are Soaring, What You Need To KnowA number of stocks jumped in the afternoon session after cooler-than-expected inflation data ignited investor optimism for a potential Federal Reserve interest rate cut. The July Consumer Price Index (CPI) report, an important measure of inflation, came in cooler than expected, showing prices holding steady at an annual rate of 2.7%. This data has led to speculation that the Federal Reserve might lower interest rates. For growth-focused sectors like SaaS, lower interest rates are particularly beneficial as they increase the present value of companies' future earnings, making their stocks more appealing.
HCAT Q2 Deep Dive: Medicaid Cuts Pressure Guidance, Profitability Initiatives Take Center StageHealthcare software provider Health Catalyst (
NASDAQ:HCAT) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 6.3% year on year to $80.72 million. On the other hand, next quarter’s revenue guidance of $75 million was less impressive, coming in 12% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was in line with analysts’ consensus estimates.
Why Health Catalyst (HCAT) Stock Is Down TodayShares of healthcare software provider Health Catalyst (
NASDAQ:HCAT)
fell 21.5% in the afternoon session after the company reported second-quarter results that met expectations but slashed its full-year revenue forecast and provided a weak outlook for the upcoming quarter. The healthcare software provider’s revenue of $80.72 million and adjusted earnings per share of $0.04 were both in line with Wall Street estimates for the second quarter. However, investors were focused on the future, as the company projected third-quarter revenue of $75 million, which was roughly 12% below analyst expectations. Furthermore, Health Catalyst cut its full-year revenue forecast by 7.5% to $310 million. While the company did beat adjusted EBITDA estimates for the quarter and raised its full-year outlook for the metric, the significant reduction in its revenue guidance overshadowed the positive news, sending shares lower.
